Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
 
VC-funded Company:


RenalGuard Solutions
459 Fortune Boulevard
Milford, MA 01757
Phone: 508-541-8800
http://www.renalguard.com/

RenalGuard Solutions, Inc. is a medical device company focused on innovative technologies for the cardiac and vascular markets. The company's lead product, RenalGuard, is designed to protect patients from acute kidney injury (AKI), including contrast-induced AKI. Investigator-sponsored studies in Europe have demonstrated RenalGuard's effectiveness at preventing CI-AKI in at-risk patients. RenalGuard is CE-marked and is sold in Europe and certain countries around the world via a network of distributors. The CIN-RG RenalGuard pivotal study is underway in the United States to support a planned Premarket Approval filing with the U.S. Food and Drug Administration.

Key Contact
NameTitleE-Mail
Ethan BenovitzCEO


Funding Events
DateAmountTypeInvestors
03/19/17$14,500,000Series A Exigent Capital
Genesis Capital Advisors
 
Massinvestor/VC News Daily
617-620-4606


© 2017 Massinvestor, Inc.